<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To determine the availability of <z:chebi fb="0" ids="28593">quinidine</z:chebi> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="28593">Quinidine</z:chebi> is the only oral medication that is effective for preventing life-threatening <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> due to <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> and idiopathic <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, because of its low price and restricted indication, this medication is not marketed in many countries </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We conducted a world survey of <z:chebi fb="0" ids="28593">quinidine</z:chebi> availability by contacting professional medical societies and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> specialists worldwide </plain></SENT>
<SENT sid="4" pm="."><plain>Physicians were e-mailed questionnaires requesting information concerning the <z:chebi fb="0" ids="28593">quinidine</z:chebi> preparation available at their hospital </plain></SENT>
<SENT sid="5" pm="."><plain>We also requested information concerning cases of adverse arrhythmic events resulting from <z:chebi fb="0" ids="28593">quinidine</z:chebi> unavailability </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: A total of 273 physicians from 131 countries provided information regarding <z:chebi fb="0" ids="28593">quinidine</z:chebi> availability: <z:chebi fb="0" ids="28593">Quinidine</z:chebi> is readily available in only 19 (14%) countries </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, this medication is not accessible in 99 (76%) countries and is available but only through specific regulatory processes that require 4-30 days for completion in 13 (10%) countries </plain></SENT>
<SENT sid="8" pm="."><plain>We were able to gather information concerning 22 patients who had serious <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> probably related (10 cases) or possibility related (12 cases) to the absence of <z:chebi fb="0" ids="28593">quinidine</z:chebi>, including 2 fatalities possibly due to <z:chebi fb="0" ids="28593">quinidine</z:chebi> unavailability </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The lack of <z:chebi fb="0" ids="28593">quinidine</z:chebi> accessibility is a serious medical hazard at the global level </plain></SENT>
</text></document>